GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (FRA:7AL0) » Definitions » Valuation Rank

Alligator Bioscience AB (FRA:7AL0) Valuation Rank


View and export this data going back to 2016. Start your Free Trial

What is Alligator Bioscience AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Alligator Bioscience AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Alligator Bioscience AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (FRA:7AL0) » Definitions » Valuation Rank
Comparable Companies
OSTO:NICA OSTO:ACTI XSAT:BIOWKS OSTO:ELIC OSTO:KAN OSTO:BIOVIC B XSAT:ABERA OSTO:PILA OSTO:MVIR NGM:GTAB B VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
ATORX:Sweden 0RK9:UK
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Website
https://www.alligatorbioscience.com
Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.